Ketorolac-fluconazole: A New Combination Reverting Resistance in Candida albicans from Acute Myeloid Leukemia Patients on Induction Chemotherapy: In vitro Study.

Shereen A SayedEhsan A B HassanMuhamad R Abdel HameedMichael N AgbanMostafa F M SalehHayam H MohammedAbu-Baker M Abdel-AalSherein G Elgendy

Published in: Journal of blood medicine (2021)

Ketorolac-fluconazole in vitro combination would be a promising strategy for further clinical in vivo trials to overcome fluconazole resistance in AML patients on induction chemotherapy.

Keyphrases

candida albicans
acute myeloid leukemia
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
squamous cell carcinoma
pseudomonas aeruginosa
radiation therapy
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia
locally advanced